The market for global angiographic catheter is estimated to increase rapidly over the forecast period of 2024-2031. Due to a growth in the number of people suffering from diabetes and the adoption of unhealthy lifestyles, the prevalence of cardiovascular illnesses is expanding at a rapid rate. This will also result in rising number of heart surgeries. All these factors led to the introduction of angiographic catheter in the market.
Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Conventional Catheters, Drug Eluting Balloon Catheters, Cutting Balloon Catheters, Scoring Balloon Catheters), Application (Coronary, Endovascular, Neurology, Oncology), Technology (X-Ray, MRA, CT), End User (Hospital, Ambulatory Surgical Centers, Cardiac Centers, Brain Centers, Specialty Clinics, Others) – Industry Trends and Forecast to 2031
.
The Global Angiographic Catheter Market size was valued at USD 1.56 USD Billion in 2023.
The Global Angiographic Catheter Market is projected to grow at a CAGR of 10.74% during the forecast period of 2024 to 2031.
The major players operating in the market include Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Cardinal Health, and many others.-.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
